Table 2.
Adeno-associated viral vectors for brain-targeted gene delivery
Type | Gene | Disease/Mechanism | Transduced Cell Types | In Vitro Cell Source | In Vivo | Result | Reference |
---|---|---|---|---|---|---|---|
AAV1 | Galactocerebrosidase (GALC) | Neurons, Astrocytes, Oligodendrocytes | Humans, mice | Twitcher (Twi) mice | Stable expression in vivo, improved myelination, symptom reduction, and increased life span | (Rafi et al., 2005) | |
AAV1 AAV2 |
Green fluorescent protein (GFP) | Neurodegenerative diseases and disorders (NDDs) | Neurons, Astrocytes, Oligodendrocytes, Microglia | C3H/HeJ mice | AAV1 transduced multiple cell types, higher efficiency and better distribution than AAV2 | (Wang et al., 2003a) | |
AAV1 AAV2 AAV8 |
CNTF | Myelin disorders | Sensory neurons, Schwann cells | CD-1 mice | AAV8: preferential Schwann cells transduction, lower immunogenicity, increased myelin and neuronal proteins associated with axonal regeneration | (Homs et al., 2011) | |
AAV1 AAV5 AAV9 AAVrh10 |
GFP | SCI | Neurons,
Astrocytes Oligodendrocytes |
SD rats | AAVrh10: Neuronal transduction efficiency was similar to other vectors but also transduced other cell types | (Petrosyan et al., 2014) | |
AAV1 AAV8 AAV9 |
GFP | Neurons, Astrocytes, Purkinje Cells | B6 mice | AAV9 most effective and sustained global expression for 18 months | (Miyake et al., 2011) | ||
AAV2 | B-cell lymphoma 2-like 2 (a.k.a. Bcl-w) | Cerebral ischemia | Neurons, Astrocytes, Ependymal Cells | MCAO in SD rats | Global expression, infarct size reduction, improved neurological function | (Sun et al., 2003) | |
GFP | Neurons, Microglia | SD rats | Neuronal expression 3 days post-infusion | (Bartlett et al., 1998) | |||
GFP | Neurons, Astrocytes | N/S | Wistar rats | Human synapsin promoter: neuronal expression in vitro, in vivo Cytomegalovirus promoter: glial expression in vitro, thalamic neurons in vivo | (Kügler et al., 2003) | ||
GFP | Neurons, Astrocytes | Cynomolgus monkeys | Neuronal expression and astrocyte activation | (An et al., 2016) | |||
GFP | Oligodendrocytes | Rats type N/S | B6 mice | Expression in white matter in vivo, oligodendrocytes in vitro due to inclusion of myelin basic protein promoter | (Chen et al., 1998) | ||
AAV2 AAV5 |
GFP, Luc | NDDs | Neurons, Astrocytes | Kainate-treated SD rats | Kainate-induction reduced transduction efficiency; AAV5 better than AAV2; AAV5 glial transduction in seizured brains | (Weinberg et al., 2011) | |
LacZ | Neurons, Astrocytes | Wistar rats | Gerbils | In vitro: AAV2 neuronal tropism, AAV5 astrocyte tropism; In vivo: higher AAV5-mediated hippocampal expression | (Nomoto et al., 2003) | ||
LacZ, Red fluorescent protein (RFP) | NDDs | Microglia | Wistar rats | SD rats | F4/80 promoter provided the best specificity compared to CD11b, CD68 promoters | (Cucchiarini et al., 2003) | |
AAV2, AAV6 | GFP | Astrocytes, Muller cells | Humans, rats | Fischer 344 rats | Higher efficiency in vitro, astrocyte, muller glia transduction ability in vivo of AAV variants generated by loop replacement | (Koerber et al., 2009) | |
GFP | Astrocytes | Human retinas, Crb1−/− mice | Astrocyte-expression with glial fibrillary acidic protein (GFAP) promoter | (Aartsen et al., 2010) | |||
AAV2 AAV9 |
GFP, L-amino acid decarboxylase | Astrocytes | SD rats, Cynomolgus monkeys | AAV2, but not AAV9, mediated protein expression without immune response | (Ciesielska et al., 2013; Samaranch et al., 2014) | ||
AAV4 | GFP, LacZ | Astrocytes, Neuronal progenitor cells | C57/BL6 mice | Expression in ependymal cells, astrocytes of subventricular zone, rostral migratory stream | (Liu et al., 2005) | ||
AAV5 | GDNF | PD | Astrocytes | MPTP-induced B6 mice, 6-OHDA-treated Wistar rats | Expression specific to the injected hemisphere, no off-target effects; same efficacy as neuron-derived GDNF; increased DA synthesis, behavioral improvement | (Drinkut et al., 2012) | |
VIVIT, a peptide that interferes with the calcineurin/nuclear factor of activated T-cells (NFAT) signaling pathway | Alzheimer’s disease (AD) | Astrocytes | Amyloid precursor protein/presenilin-1 mice | Reduced glial activation, amyloid levels, improved cognitive and synaptic function | (Furman et al., 2012) | ||
AAV8 AAVcy5 AAVrh20 AAVrh39 AAVrh43 |
GFP | Neurons, Astrocytes, Oligodendrocytes | SD rats | Preferential astrocyte and oligodendrocyte transduction with AAV8 and AAVrh43 using cell-specific promoters | (Lawlor et al., 2009) | ||
AAV8, AAV9 | GFP, mCherry | Neurons, Astrocytes | B6 mice | AAV8 astrocyte tropism and AAV9 neuronal tropism; single complementary (sc) AAV better than single strand (ss) AAV | (Aschauer et al., 2013) | ||
AAV9 | Erythropoietin (EPO) | PD | Neurons, Astrocytes | 6-OHDA treated SD rats | Prior intramuscular injection reduced intrastriatal transduction efficiency due to circulating antibodies to AAV and EPO | (Yang et al., 2013) | |
GFP | Amyotrophic lateral sclerosis | Neurons, Astrocytes | B6 mice | Crosses blood-brain barrier, neonatal mice: neuronal tropism, adult mice: astrocyte tropism | (Foust et al., 2009) | ||
GFP | Spinal muscular atrophy (SMA) | Motor neurons, Astrocytes | Survival motor neurons Δ7 and B6 mice | Intramuscular injection transduced spinal cord motor neurons, astrocytes; increased median lifespan | (Benkhelifa-Ziyyat et al., 2013) | ||
GFP | SMA | Neurons, Astrocytes, Oligodendrocytes | Cynomolgus monkeys | Global CNS expression at different ages; selective CNS expression by cerebrospinal fluid delivery | (Bevan et al., 2011) | ||
GFP | Neurons, Astrocytes | BALB/C mice, Rhesus macaques | Higher neuronal expression in rodent, higher glial expression in NHPs, scAAV efficient than ssAAV | (Gray et al., 2011) | |||
GFP | Neurons, Astrocytes | MF1 mice | Neuronal tropism in fetal mice, astrocyte tropism in neonatal mice; ssAAV efficient than scAAV | (Rahim et al., 2011) | |||
GFP | Neurons, Astrocytes | B6 mice | Neonatal mice: astrocyte tropism; young mice: neuronal tropism | (Gholizadeh et al., 2013) | |||
GFP | Neurons, Astrocytes | B6 mice | Intrathecal delivery efficient than intravenous delivery | (Schuster et al., 2015) | |||
GFP | Neurons, Astrocytes | SD rats, farm mice | Dose-dependent increase in global transduction, no astrogliosis | (Donsante et al., 2016) | |||
Glutamine synthetase, excitatory amino acid transporter, micro RNA targeting adenosine kinase (miADK) | Temporal lobe epilepsy | Astrocytes | Kainate-treated SD rats | miADK reduced seizure duration | (Young et al., 2014) | ||
β-galactosidase | GM1-gangliosidosis | N/S | GM1 mice | Reduced astrogliosis, improved behavior and median survival, moderate CNS expression | (Weismann et al., 2015) | ||
AAV9 AAVrh10 |
GFP | Neurons, Astrocytes | B6 mice | Efficient transduction without inflammatory response | (Zhang et al., 2011) | ||
AAVrh8 AAVhu32 AAVhu37 AAVpi2A AVhu48R3 |
GFP | Neurons, Astrocytes, Oligodendrocytes | C3H/HeOuJ mice | Neuronal transduction by all serotypes, astrocyte and oligodendrocyte transduction by certain serotypes | (Cearley et al., 2008) |